Home Pilots Lunit receives $150M capital chip-in, doubles down on US market Pilots Lunit receives $150M capital chip-in, doubles down on US market By - November 16, 2023 56 0 Facebook Twitter Pinterest WhatsApp It has also obtained its third US FDA 510(k) clearance. RELATED ARTICLESMORE FROM AUTHOR Pilots Leidos, University of Pittsburgh spend $10M for AI disease detection Pilots HealthMed, Podimetrics partner to help high-risk patients with diabetes Pilots Digital dementia support project gets $2M federal funding and more briefs LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Deep-learning algorithm detects diabetic retinopathy on par with regional specialists Pilots - April 18, 2022 0 Carrum Health, Florida Cancer Institute partner to expand breast cancer care Pilots - December 27, 2023 0 Hackensack Meridian Health, CancerIQ partner on cancer risk, early detection program Pilots - August 27, 2024 0 Roundup: Oxford Drug Design raises £2.2M to develop AI programme, Rune Labs launch Portuguese... Pilots - May 19, 2022 0 Royal Philips rolls out at-home ECG system for decentralized clinical trials Pilots - January 26, 2022 0 POPULAR CATEGORIESPilots2251Applications807Testing283Collaborations15GitHub3
